Upcoming Medical Conferences in Boston

3rd Annual PREDiCT: 3D Models Summit is organized by Hanson Wade and will be held from Aug 21 - 23, 2018 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America. Course Description: The 3rd PREDiCT:3D Models Summit (previously 3D Tissue Models) will continue to showcase disruptive preclinical strategies utilizing advanced in vitro models across target ID, compound discovery, safety assessment, ADMET studies and more. Representing the continued investment of biopharma into the area, this year over 34 speakers from more than 30 pharma, academia, government and model development organizations have committed to present. Serving up an unrivalled volume of content, PREDiCT: 3D Models Summit will drill into case studies across discovery and development areas to enable you to determine the practicality of 3D models in optimizing your therapeutic pipeline. Speakers: Kristin Fabre,Matthew Wagoner ,Brian Berridge ,Adrian Roth ,John Wikswo ,Joseph Charest ,J. Eric McDuffie ,Fabian Zanella ,B. Prabhakar Pandian,Misti Ushio,Darrell Kotton ,Terry Van Vleet,Brian Wamhoff ,Silvia Krause ,Ajamete Kaykas ,Alejandro Amador,Andreas R. Baudy,Anita Seshire ,Anna M Sitarski ,Bhushan Mahadik ,Dominic Williams ,Graham Marsh ,Hicham Alaoui ,James Morelli ,Jinping Gan ,John K. Westwick ,Piyush Pajaj ,Dik C. van Gent ,Dominic Williams ,Rhiannon Hardwick,Sarah Hoyle ,Swati Gupta ,Szczepan Baran ,Thomas Knudsen ,Zhen Ma ,Edward Kelly Time: 07:30 to 18:00. Additional details will be posted as soon as they are available.

Three-Dimensional TEE Workshop is organized by Harvard Medical School (HMS), Beth Israel Deaconess Medical Center (BIDMC) and will be held from Aug 25 - 26, 2018 at Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America. The target audience for this medical event is targeted to HMS-Affiliated, Regional/Local, National, and International Specialty Physicians who practice in Anesthesiology or Cardiology. This CME Conference has been approved for a maximum of 15.00 AMA PRA Category 1 Credits. Course Description: This interactive, hands-on course will provide learners the opportunity to learn three-dimensional transesophageal echocardiography (3D TEE) imaging techniques, using mannequins and real 3D TEE equipment. There will also be formal didactic lectures and opportunities for learners to ask the faculty questions prior to each hands-on session. Didactic sessions will reinforce theoretical concepts and ensure that the participants have a positive educational experience. Learning Objectives: Upon completion of this activity, participants will be able to: • Operate 3D TEE equipment and perform a comprehensive 3D TEE examination. • Acquire and perform quantitative analysis of mitral, tricuspid, and aortic valves. • Volumetrically analyze left and right ventricle. • Develop strategies to utilize new information to assist in surgical decision-making. Additional details will be posted as soon as they are available.

Lean Six Sigma White Belt is organized by Boston Children's Hospital and will be held on Aug 28, 2018 at Boston Children's Hospital, Boston, Massachusetts, United States of America. The target audience for this medical event is Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists, Health Care Administration. This CME Conference has been approved for a maximum of 7.00 AMA PRA Category 1 Credits. Course Description: Continuous Improvement Training – Lean Six Sigma White Belt: Process Improvement Tools This conference is a combination of two proven continuous improvement methods: Lean and Six Sigma. Lean Six Sigma is focused on creating value for customers by improving efficiency, safety, and quality while reducing waste and variation. Want to change the world but not sure how? Learn some important process improvement tools that can help drive change in your part of the world. This goal of this introductory course is to teach the mindset and tools that are fundamental to the success of Lean and Six Sigma in healthcare. • White Belt is led by real world practitioners, giving participants insight on how to apply these tools in their own job. • The day is meant to be interactive throughout, with small group exercises, class discussion, video examples and active learning opportunities • Through the use of a simulated Emergency Department, participants get to apply six specific tools to improve a process: Eight Wastes, Process Mapping, Fishbone, 5S, Mistake Proofing, and Standard Work. Course Objectives: • Describe the concept of involving everyone in continuous improvement • Discuss improving processes • Discuss the reasons for change • Explain methodologies for continuous improvement used at the hospital • Recognize the requirements for change • Discuss methodologies for embracing change • Explain the need to view things from the customer’s perspective and practice empathetic listening techniques • Practice in a simulated process • Discuss some process analysis tools and identify 9 wastes • Define flow and determine how to clarify the flow of a process • Explain a fishbone diagram • Describe how to report an adverse event • Describe some continuous improvement tools and explain the 6S tool • Explain the mistake proofing concept • Explain the problem with variation in the process and how standard work helps • Apply analysis and improvement tools to a simulated process • Develop an action plan Additional details will be posted as soon as they are available.

Immuno-Oncology Summit 2018 is organized by Cambridge Healthtech Institute (CHI) and will be held from Aug 28 - 29, 2018 at Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.

Lean Six Sigma Yellow Belt is organized by Boston Children's Hospital and will be held on Aug 29, 2018 at Boston Children's Hospital, Boston, Massachusetts, United States of America. The target audience for this medical event is Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists, Health Care Administration. This CME Conference has been approved for a maximum of 7.00 AMA PRA Category 1 Credits. Course Description : Continuous Improvement Training – Lean Six Sigma Yellow Belt: Leading Process Improvement Projects This conference is a combination of two proven continuous improvement methods: Lean and Six Sigma. Lean Six Sigma is focused on creating value for customers by improving efficiency, safety and quality, while reducing waste and variation. Build on the tools learned in the White Belt class to understand how to lead process improvement projects. Participants learn how to use a proven five-step methodology called, DMAIC, to drive change in their organization. Specific tools and topics are covered for each of the five steps and participants are given the opportunity to practice in small groups. • Yellow Belt is led by real world practitioners, giving participants insight on how to apply these tools in their own job. • The day is meant to be interactive throughout, with small group exercises, class discussion, video examples and active learning opportunities • Included in the course: Team Charter, Value Analysis, Flow, Operational Definitions, 5 Why’s, Understanding Variation, Pareto Chart, Creative Thinking, Kanban, Visual Management, and Run Charts. Course Objectives: • Describe the concept of involving everyone in continuous improvement • Explain the concept of leadership as part of everyone’s life • Describe the background, principles and tenets of Lean and Six Sigma and how it relates to the hospital • Explain Shewhart’s (Deming’s) PDCA/PDSA cycle • Describe the current continuous improvement projects and effort at the hospital • Define the meaning of a “process” • Explain the five-step continuous improvement methodology, DMAIC • Recognize a well-written charter • Review the use of a process map for looking at flow • Identify customer, operational and non-value added activities on a process flow diagram • Discuss the importance of an operational definition • Be able to recognize a well-written operational definition • Describe the 5 Why’s tool. Introduce basic statistical concepts including mean and standard deviation • Explain the Pareto Chart • Discuss creative thinking techniques • Explain Kanban concepts and implementation • Explain the concept of visual management • Describe the use of a run chart • Design an action plan Additional details will be posted as soon as they are available.

4th Annual CAR-TCR Summit 2018 - Changing Lives with CAR-T & TCR Cell Immunotherapies is organized by Hanson Wade and will be held from Sep 04 - 07, 2018 at Seaport Hotel & World Trade Center, Boston, Massachusetts, United States of America. The CAR-TCR Summit is the only dedicated, end-to-end summit focused on accelerating to market the next generation of potent, safe and efficacious CAR-TCR therapies for solid tumor indications, whilst ensuring the accessibility and commercial delivery of currently approved life-changing CAR-TCR therapies to patients around the world. Now four years established, the CAR-TCR Boston Summit continues to aspire to help the field realize the scientific potential and cure all cancer patients with breakthrough CAR-T & TCR cell therapies. Through industry defining, passionate and comprehensive content, the CAR-TCR Summit is dedicated to achieving two main goals: • Accelerate the discovery, translation and clinical development of more effective and potent CAR-T & TCR therapies for solid tumor indications, exploring innovative technology solutions to overcome genetic engineering, safety, tumor microenvironment and manufacturing scalability challenges • Whether pursuing allogeneic or autologous approaches, ensure the accessibility, affordability and logistical delivery of current CAR-T cell therapies to patients in need around the world, defining best practice to overcome regulatory, pricing and reimbursement hurdles With two CD19 approved drugs and the space getting increasingly crowded, this year's CAR-TCR Summit will leverage the experience from those leaders first to market, whilst unveiling the next generation technologies and breakthroughs being developed to enhance CAR-TCR efficacy in solid tumor indications. Become part of a dedicated community striving to deliver "curative" CAR-T And TCR cell therapies to patients in need. Take an in-depth dive through the full end-to-end development process, from basic research through to patient delivery. We will gather the industry’s experts to discuss: • Novel innovations to improve CAR-TCR solid tumor targeting • Mechanisms to overcome the tumor microenvironment • Clinical development to identify biomarkers of response • Automation and manufacturing processes to reduce the overall cost of goods and improve turn around time • Streamlined logistics of vein to vein delivery • Regulations and reimbursement to ensure accessibility and global commercial delivery Prices: 2 Day Conference + Focus Day AND Discussion Day (Drug Developers And Biotech Price): USD 4997.0 2 Day Conference + Focus Day OR Discussion Day (Drug Developers And Biotech Price): USD 3998.0 2 Day Conference (Drug Developers And Biotech Price): USD 2799.0 2 Day Conference + Focus Day AND Discussion Day (Academic Price): USD 3997.0 2 Day Conference + Focus Day OR Discussion Day (Academic Price): USD 2998.0 2 Day Conference (Academic Price): USD 1799.0 2 Day Conference + Focus Day AND Discussion Day (Standard Price): USD 5997.0 2 Day Conference + Focus Day OR Discussion Day (Standard Price): USD 4998.0 2 Day Conference (Standard Price): USD 3799.0 Speakers: Jmaes Noble , Mark Dudley , Eric Van Hofe , Paul Rennert, David Chang , Jim Faulkner, Jamie Margolis , Peter Olagunju, Philip Gregory , Rick Morgan , Andy Philips, Jennifer Fillman, Steven Kelly, Zonghai Li, Stefanos Theoharis , Andre Choulika, David Sourdive, Benham Badie, Mike Stella, Mark Sawicki, Charles Sentman, Chris Leamon , Edmund Pezalla, Bijan Nejadnik, Cheng Liu, Bob Valamehr, Jim Beitel, Richard Grant , Philip Vanek, Robert Preti, Cameron Durrant, Eileen Higham , Ali Mohamed , Steffen Walter , Sean MacKay, John Rossi, Peter Emtage , Yuan Xu, Bala Manian, Nina Bauer , Saad Kenderian , Dolores Schendel , Isabelle Riviere , Boro Dropulic , Sadik Kassim, James Kochenderfer , Steven Feldman , Mario Marcondes , Rona Singer Weinberg , Koji Tamada , Rodney Rietze, Samuele Butera , Therese Choquette, Yajin Ni, Vita Golubovskaya, Scott Ohanesian, Barbra Sasu , Gary Lee, Michael Leek, Robert Hofmeister , John Connolly, John Ellis , Usman Azam , Thomas Andersen, Jeffrey Tice, Avery Posey , Bruce Levine , Carl June , David Porter , Roderick O' Connor , Simon Lacey , Miguel Forte Time: 7:00 am to 6:30 pm

Anesthesia Crisis Resource Management (ACRM)-1 is organized by Center for Medical Simulation (CMS) and will be held on Sep 04, 2018 at Center For Medical Simulation, Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.

Cell & Gene Therapy Bioprocessing & Commercialization is organized by KNect365 Life Sciences and will be held during Sep 04 - 07, 2018 at Hynes Convention Center, Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.

Pain CRM Workshop is organized by Center for Medical Simulation (CMS) and will be held on Sep 04, 2018 at Center For Medical Simulation, Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.

Microbiome Therapeutics US is organized by KNect365 Life Sciences and will be held from Sep 05 - 06, 2018 at Hynes Convention Center, Boston, Massachusetts, United States of America. Who should attend? • Pharma/Biopharma/Biotech / Consumer Packaged Goods: • Scientists/ Researchers/ Project leaders/ VPs/ Heads/ Director/ C-Level working in: ○ Microbiome Therapeutics ○ R&D and Drug Development ○ Translational & Clinical Development ○ Regulatory Affairs ○ Manufacturing & Formulation ○ Commercialization & Business Development ○ Gut/Gastroenterology, Skin, Oral, Vaginal, Autoimmune, Metabolic, Oncology, Infectious Diseases ○ Immunology ○ Biochemistry, Biosystems and Biomaterials • Vendor/ Technology Providers /Consultants: ○ Investment Community ○ Genomic / Sequencing / Data Analysis Solution Providers ○ Drug Development and Model Providers • Academia & Microbiome Research Organizations: ○ Scientists/Professors/Researchers/Project Leaders Course Description: Microbiome Therapeutics US brings together leading experts from across the human microbiome therapeutics field to explore the latest progress in finding the most effective route from microbiome drug discovery through to commercial success. The meeting provides the ultimate platform to get involved in the latest discussions with like-minded professionals surrounding the latest clinical trials, manufacturing and scale-up challenges, funding solutions and commercialization strategies to take these products to market. Join the likes of Flagship Pioneering, Siolta Therapeutics, Finch Therapeutics and many more to benchmark your end-to-end microbiome drug strategy with practical industry insights, case studies, shared experiences and lessons learned to help you stay ahead of the curve. Plus, ensure you're up to date with the latest regulatory guidance with direct feedback from the FDA and seek out funding opportunities to take your pipeline to the next level. Speakers: Julia Barrett, Senior Clinical Consultant at Biologics Consulting, Keith Batchelder, MD, CEO and Founder at Genomic Healthcare Strategies, JP Benya, VP, Commercial at Assembly Biosciences, David Berry, Partner at Flagship Pioneering, Rodolphe Clerval, CBO at Enterome, David Donabedian, PhD, CEO, Co-Founder at Axial Biotherapeutics, Akintunde Emiola, PhD, PostDoctoral associate at The Jackson Laboratory, Michalis Hadjithomas, Microbiome Lead Scientist at DNANexus, Zain Kassam, MD, co-founder and Executive VP at Finch Therapeutics, Nikole Kimes, PhD, Founder and Chief Scientific Officer at Siolta Therapeutics, David Kyle, CEO at Evolve BioSystems Inc, Robert Langer, SCD, David H. Koch Institute Professor at Massachusetts Institute of Technology, Mark Smith, CEO at Finch Therapeutics, Erik Spek, PhD, Vice President, Head of Intellectual Property at Vedanta Biosciences, Inc., Lily Ting, PhD, Head of RandD at Commense, Kamal Velmurugan, Microbiologist, Primary Reviewer at FDA, James Weston, MBA, Senior Vice President of Regulatory Affairs at Seres Therapeutics. Time: 8:00 am - 6:30 pm. Additional details will be posted as soon as they are available.